Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 21556 AL 21570

Early Alzheimer's and Parkinson's disease pathology in urban children: Friend versus Foe responses--it is time to face the evidence

Calderón-Garcidueñas L, Franco-Lira M, Mora-Tiscareño A, Medina-Cortina H, Torres-Jardón R, Kavanaugh M.

Biomed Res Int. 2013;2013:161687. doi: 10.1155/2013/161687. Epub 2013 Feb 7.

Ghrelin as a neuroprotective and palliative agent in Alzheimer's and Parkinson's disease

Dos Santos VV, Rodrigues AL, De Lima TC, de Barioglio SR, Raisman-Vozari R, Prediger RD.

Curr Pharm Des. 2013;19(38):6773-90. doi: 10.2174/13816128113199990411.

α-Synuclein in cerebrospinal fluid of Alzheimer's disease and mild cognitive impairment

Korff A, Liu C, Ginghina C, Shi M, Zhang J; Alzheimer’s Disease Neuroimaging Initiative.

J Alzheimers Dis. 2013;36(4):679-88. doi: 10.3233/JAD-130458.

[Smoking and neurological disorders]

Fujii H, Hosomi N, Matsumoto M.

Nihon Rinsho. 2013 Mar;71(3):423-9.

Progress in stem cell therapy for major human neurological disorders

Martínez-Morales PL, Revilla A, Ocaña I, González C, Sainz P, McGuire D, Liste I.

Stem Cell Rev Rep. 2013 Oct;9(5):685-99. doi: 10.1007/s12015-013-9443-6.

Developmental neuroplasticity and the origin of neurodegenerative diseases

Schaefers AT, Teuchert-Noodt G.

World J Biol Psychiatry. 2016 Dec;17(8):587-599. doi: 10.3109/15622975.2013.797104. Epub 2013 May 24.

Ascending monoaminergic systems alterations in Alzheimer's disease. translating basic science into clinical care

Trillo L, Das D, Hsieh W, Medina B, Moghadam S, Lin B, Dang V, Sanchez MM, De Miguel Z, Ashford JW, Salehi A.

Neurosci Biobehav Rev. 2013 Sep;37(8):1363-79. doi: 10.1016/j.neubiorev.2013.05.008. Epub 2013 May 24.

Metal dyshomeostasis and inflammation in Alzheimer's and Parkinson's diseases: possible impact of environmental exposures

Myhre O, Utkilen H, Duale N, Brunborg G, Hofer T.

Oxid Med Cell Longev. 2013;2013:726954. doi: 10.1155/2013/726954. Epub 2013 Apr 17.

Evaluation of Parkinson disease and Alzheimer disease with the use of neuromelanin MR imaging and (123)I-metaiodobenzylguanidine scintigraphy

Miyoshi F, Ogawa T, Kitao SI, Kitayama M, Shinohara Y, Takasugi M, Fujii S, Kaminou T.

AJNR Am J Neuroradiol. 2013 Nov-Dec;34(11):2113-8. doi: 10.3174/ajnr.A3567. Epub 2013 Jun 6.

Comparison of quantitative EEG between patients with Alzheimer's disease and those with Parkinson's disease dementia

Fonseca LC, Tedrus GM, Carvas PN, Machado EC.

Clin Neurophysiol. 2013 Oct;124(10):1970-4. doi: 10.1016/j.clinph.2013.05.001. Epub 2013 Jun 5.

Caring for parents with neurodegenerative disease: a qualitative description

Habermann B, Hines D, Davis L.

Clin Nurse Spec. 2013 Jul-Aug;27(4):182-7. doi: 10.1097/NUR.0b013e318295576b.

Amyloid beta-induced glycogen synthase kinase 3β phosphorylated VDAC1 in Alzheimer's disease: implications for synaptic dysfunction and neuronal damage

Reddy PH.

Biochim Biophys Acta. 2013 Dec;1832(12):1913-21. doi: 10.1016/j.bbadis.2013.06.012. Epub 2013 Jun 28.

Different β-amyloid binding patterns in Alzheimer and Parkinson diseases: it's the network!

Eidelberg D, Martin W.

Neurology. 2013 Aug 6;81(6):516-7. doi: 10.1212/WNL.0b013e31829e703e. Epub 2013 Jul 3.

Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome

Salminen A, Kaarniranta K, Kauppinen A, Ojala J, Haapasalo A, Soininen H, Hiltunen M.

Prog Neurobiol. 2013 Jul-Aug;106-107:33-54. doi: 10.1016/j.pneurobio.2013.06.002. Epub 2013 Jul 1.

Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies

Irwin DJ, Lee VM, Trojanowski JQ.

Nat Rev Neurosci. 2013 Sep;14(9):626-36. doi: 10.1038/nrn3549. Epub 2013 Jul 31.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias